Tag: San Francisco
JPM Day 3 Recap: Key Topic of Discussion
Chinese Drug Candidates Key Topic at JPM ConferenceIn the bustling city of San Francisco, where the biotech world converges, the J.P. Morgan Healthcare Conference is abuzz with discussions about the growing prominence of Chinese...
Cytokinetics CEO: Not Pursuing Acquisition, Company Focuses on Growth
Breaking News: Cytokinetics CEO Firm on Company Growth Amid Drug ApprovalIn a recent interview, Cytokinetics CEO Robert Blum made it abundantly clear that despite rumors of a potential acquisition, the company is focused solely...
Latest Health Tech Deals Revealed Before JPM Conference
Latest Health Tech Deals Revealed Before JPM ConferenceIn an exciting development for the health tech industry, the Food and Drug Administration (FDA) recently released new draft guidance aimed at developers of medical devices that...
New Biotech Firm Raises $300 Million with Focus on Heart Disease
**New Biotech Firm Raises $300 Million with Focus on Heart Disease**In a bold move that has sent shockwaves through the biotech industry, MyoKardia's former CEO, Tassos Gianakakos, has announced the launch of a new...
Biotech’s Annual SF Gathering: Guide to JPM Week
Biotech's Annual SF Gathering: Guide to JPM WeekThe biopharma world is gearing up for one of its most significant events of the year as JPM Week kicks off in San Francisco this Sunday. This...
